Nostrum BioDiscovery, a new spin-off of the University of Barcelona, the IRB Barcelona, the BSC-CNS and the ICREA

A moment during the presentation of the company.
A moment during the presentation of the company.
Research
(13/07/2016)

This morning in Barcelona, the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) have presented the spin-off Nostrum BioDiscovery, a new biotech company that applies computational simulation to help new drugs and biotech molecules to reach the market. The creation of this spin-off has also been made possible thanks to the Bosch i Gimpera Foundation of the University of Barcelona and the Catalan Institute for Research and Advanced Studies (ICREA).

The creation and launch of the company has been driven by the Botín Foundation, whose technology transfer programme has provided one of the research groups involved support and assessment over five years. Furthermore, the Botín Foundation has invested half a million euros of start-up capital in Nostrum BioDiscovery through its Mind the Gap Programme, which backs early-stage entrepreneurial projects.

Further information.

A moment during the presentation of the company.
A moment during the presentation of the company.
Research
13/07/2016

This morning in Barcelona, the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) have presented the spin-off Nostrum BioDiscovery, a new biotech company that applies computational simulation to help new drugs and biotech molecules to reach the market. The creation of this spin-off has also been made possible thanks to the Bosch i Gimpera Foundation of the University of Barcelona and the Catalan Institute for Research and Advanced Studies (ICREA).

The creation and launch of the company has been driven by the Botín Foundation, whose technology transfer programme has provided one of the research groups involved support and assessment over five years. Furthermore, the Botín Foundation has invested half a million euros of start-up capital in Nostrum BioDiscovery through its Mind the Gap Programme, which backs early-stage entrepreneurial projects.

Further information.